Clinical Trial Update: FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating different outcome measures for the effect of Fampyra in multiple sclerosis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampyra (fampridine)

Snippet

Sponsor: University of Southern Denmark | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED